Mark Kendall (engineer)
From Wikipedia, the free encyclopedia
Mark Kendall | |
|---|---|
In an ANU video in 2018 | |
| Born | 16 April 1972 |
| Occupation | Biomedical engineer |
| Employer | Australian National University |
| Known for | Biomedical invention |
Mark A. F. Kendall (FTSE FRSA FNAI) (born 1972) is an Australian biomedical engineer, inventor, scientist and entrepreneur.
He is founder and CEO of WearOptimo Pty Ltd[1] and the Vice-Chancellor's Entrepreneurial Professor at the Australian National University.[2]
Kendall serves at the co-chair of the $150 million Australian Stem Cell Therapies Mission[3] and on the World Economic Forum Global Future Council on Biotechnology.[4]
Kendall's contributions to innovation in global healthcare has been recognised with more than forty awards. These include elections as:
- World Economic Forum Technology Pioneer (2015).[5]
- Fellow of ATSE; Australian Academy of Technological Sciences and Engineering (2017).[6]
Kendall is a CSL Young Florey Medallist[7] and Rolex Laureate.[8][9]
Kendall's work regularly features in international media, including on the National Geographic Channel.[10]
Kendall's TedGlobal talk has been viewed more than a million times.[11]
Kendall was born on 16 April 1972.[12] He received his Bachelor of Engineering (Hons I, 1993) and PhD (1998) from the University of Queensland.[13]
In 1998, Kendall moved to the UK to take up a position in the Department of Engineering Science at the University of Oxford (1998–2006).[citation needed]
Contributions to biotechnology
At the University of Oxford[13] (1998–2006) Kendall developed a biolistic technique for the delivery of vaccines directly into the skin without the use of needles.
At the University of Queensland (2006–2018) Kendall invented the Nanopatch[14][15] for needle-free delivery of vaccines.[16][17]
At WearOptimo[1] and the Australian National University[18] (2018 to present), Kendall has invented the Microwearable™[19] sensor for personalised medicine.
During his career, Kendall has collaborated with major global health partners including the Bill & Melinda Gates Foundation,[20] World Health Organization[21][22] and Merck & Co.[23]
He is an Australian Government Academy of Science COVID-19 Expert.[24]